Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD

The use of inhaled, fixed-dose, long-acting muscarinic antagonists (LAMA) combined with long-acting, beta(2)-adrenergic receptor agonists (LABA) has become a mainstay in the maintenance treatment of chronic obstructive pulmonary disease (COPD). One of the fixed-dose LAMA/LABA combinations is the dry...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Chron Obstruct Pulmon Dis
Autori principali: Albertson, Timothy E, Bowman, Willis S, Harper, Richart W, Godbout, Regina M, Murin, Susan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2019
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6559138/
https://ncbi.nlm.nih.gov/pubmed/31239659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S191845
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi